Why the study?
In complicated pediatric SARS-CoV-2 infection, it is unknown whether inflammation predicts disease severity, and cardiac involvement is only anecdotally described.
Severe SARS-CoV-2 infection in infants can present with cardiac involvement such as myocarditis, which may be treated with immunoglobulins.
Answers are grounded in this paper and cite their sources.
Myocarditis may complicate infant SARS-CoV-2; single case leaves open IL-6 as severity predictor in children.
Severe acute respiratory syndrome coronavirus 2 infection in children mainly shows a milder course. In complicated cases, it is unknown whether inflammation is predictive of disease severity, as in adults. Moreover, cardiac involvement is anecdotally described. We report the case of a 2-month-old infant with severe acute respiratory syndrome coronavirus 2 infection presenting with fever, tachycardia and elevated interleukin-6, who was diagnosed with myocarditis and treated with immunoglobulins.
No takes yet. Share an insight, caveat, or question.
Giacomet et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: